... enough to achieve long-term health benefits. Inclusion Criteria: 1) adult 18 years or older without ...
... al., 2016; Kaplan et al., 2018; Rubino et al., 2021; Updike, 2021; Wharton et al. 2022). In 2017 ...
... glucagon-like-peptide (GLP-1) to combat the obesity and diabetic epidemic. Project: 21 days in length with ...
... two data collection periods. GLP-1 prompts the body to produce more insulin, reducing blood sugar ...
... (glucose). GLP-1 in higher amounts interacts with parts of the brain to suppress appetite and signal ...